Table 5.
Analytes | HOMA < 2.5 (n = 24) | HOMA ≥ 2.5 (n = 20) | p |
---|---|---|---|
SCD40L | 193.5 (156.6–439.8) | 271.6 (170.4–400) | 0.494 |
TNF-α | 16.5 (12.4–22.5) | 11.5 (10–20.3) | 0.069 |
TNF-β | 9.4 (5.2–16.3) | 4.9 (1.8–16.9) | 0.268 |
FKN | 147.3 (130.7–241.2) | 130.7 (101.6–204.8) | 0.140 |
MIG | 685.7 (535.7–842.3) | 693.7 (574.5–772.1) | 0.786 |
GRO-α | 1.14 (0.42–2.94) | 0.42 (0.12–1.81) | 0.126 |
MCP-1 | 166.2 (139.5–189.3) | 154 (101.5–191) | 0.258 |
MCP-3 | 11.9 (6.5–20.8) | 8.4 (4.9–20.4) | 0.457 |
MIP-1α | 15.9 (8.0–29.6) | 18.2 (10.6–25.9) | 0.972 |
MIP-1β | 16.7 (12.5–20.4) | 18.6 (14.9–22.5) | 0.216 |
Eotaxin | 53.9 (44.9–63.9) | 37.4 (30–45) | 0.001 |
SCD40L—soluble CD40 and its ligand, TNF-α—tumor necrosis factor alpha, TNF-β—tumor necrosis factor beta, FKN—fractalkine, GROa—chemokine ligand 1, MIG—monokine-induced gamma interferon, MCP-1—monocyte-chemoattractant protein 1, MCP-3—monocyte-chemotactic protein 3, MIP-1α—macrophage inflammatory protein 1-alpha, MIP-1β—macrophage inflammatory protein 1-beta.